Mov Disord Vol 33, Suppl 2 Archives - Page 138 of 177 - MDS Abstracts

2018 International Congress
Systemic variables that exacerbated physiological tremor in a general hospital in Mexico
D. Rebolledo, O. Gonzalez, J. Rebolledo, Z. Rebolledo (Toluca de Lerdo, Mexico)
Objective: To determine the relationship between the etiological variables of the exacerbated physiological tremor in the emergency, hospitalization and intensive care services in a general…
2018 International Congress
Working memory maintenance and manipulation in Parkinson’s disease: An fMRI study
K. Giehl, A. Ophey, J. Hammes, S. Rehberg, C. Eggers, T. Lichtenstein, D. Maintz, E. Kalbe, T. van Eimeren (Cologne, Germany)
Objective: This study aimed to investigate the neural correlates of different working memory (WM) aspects in Parkinson's disease (PD) patients using a newly designed WM…
2018 International Congress
The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors
K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)
Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…
2018 International Congress
Reproductive factors influence on cognitive function of Parkinson’s disease in female patients-from a cross-sectional study
Y. Wu, H. Liu, R.W. Ou, Q.Q. Wei, H.F. Shang (Chengdu, People’s Republic of China)
Objective: To explore the relationship between the female reproductive factors and cognitive decline/dementia with PD Background: Cognitive dysfunction was the common non-motor features of Parkinson’s…
2018 International Congress
Biomarkers of rapid progression of cognitive decline in Parkinson’s disease
S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, J. Marin-Lahoz, A. Horta-Barba, H. Bejr-Kasem, I. Aracil, J. Perez-Perez, MA. Boti, J. Kulisevsky. (Barcelona, Spain)
Objective: We aimed to explore cross-sectional grey-matter volume (GMV) and CSF biomarkers differences in PD patients exhibiting a rapid progression of cognitive decline compared to…
2018 International Congress
Clinical phenotype analysis of Parkinson’s disease associated with LRRK2 variants in Chinese Han population
C. Gu, K. Li, J. Zhang, H. Jin, Y. Ge, C. Liu (Suzhou, China)
Objective: Our study aimed to compare motor and non-motor symptoms, imaging features and molecular markers of patients with Parkinson’s disease (PD) who are carriers of…
2018 International Congress
Comparison of thermal sensation and pain thresholds in LRRK2 carriers and non carriers with Parkinson’s disease
A. Khlebtovsky, Y. Roditi, R. Djaldetti (Petach Tikva, Israel)
Objective: To compare between clinical findings and quantitative sensory testing (QST) data in patients with Parkinson's disease (PD) positive and negative for mutations in LRKK2.…
2018 International Congress
Acid sphingomyelinase deficiency rescues mitochondrial dysfunction in gba-/- zebrafish (Danio rerio)
M. Keatinge, L. Trollope, H. Mortiboys, O. Bandmann (Sheffield, United Kingdom)
Objective: To determine the interaction between glucocerebrosidase deficiency and acid sphingomyelinase deficiency in a tractable vertebrate model system of Parkinson's disease. Background: Heterozygous glucocerebrosidase (GBA)…
2018 International Congress
Tef polymorphism predicts the decline of sleep disturbances in Parkinson’s disease
P. Hua, W. Liu (Nanjing, China)
Objective: Circadian dysfunction may contribute to the etiology of motor and non-motor symptoms of Parkinson’s disease (PD). The influence of polymorphisms of Cry1 rs2287161, Cry2…
2018 International Congress
eEF1A2 and Prdx1 as possible new targets for Parkinson’s disease therapeutics
W. Wirakiat, P. Dharmasaroja (Bangkok, Thailand)
Objective: We investigated expression of eEF1A2 and Prdx1 in differentiated SH-SY5Y cells in searching for possible new targets for Parkinson’s disease treatment. Background: Parkinson’s disease…